Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT02537418 |
| Title | Durvalumab With or Without Tremelimumab in Advanced Incurable Solid Malignancies Receiving Standard Chemotherapy Regimens |
| Recruitment | Active, not recruiting |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | NCIC Clinical Trials Group |
| Indications | |
| Therapies | |
| Age Groups: | adult |
| Covered Countries | CAN |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Tom Baker Cancer Centre | Calgary | Alberta | T2N 4N2 | Canada | Details | |
| BCCA - Vancouver Cancer Centre | Vancouver | British Columbia | V5Z 4E6 | Canada | Details | |
| Juravinski Cancer Centre at Hamilton Health Sciences | Hamilton | Ontario | L8V 5C2 | Canada | Details | |
| Cancer Centre of Southeastern Ontario at Kingston | Kingston | Ontario | K7L 5P9 | Canada | Details | |
| Ottawa Hospital Research Institute | Ottawa | Ontario | K1H 8L6 | Canada | Details | |
| University Health Network | Toronto | Ontario | M5G 2M9 | Canada | Details | |
| CHUM - Hopital Notre-Dame | Montreal | Quebec | H2L 4M1 | Canada | Details |